Shaanxi Panlong Pharmaceutical Hits Day Low Amid Price Pressure at CNY 29.49

Shaanxi Panlong Pharmaceutical Group has experienced a significant decline today, with the stock dropping by 7.78% as of July 17, 2026. The stock reached an intraday low of CNY 29.49, reflecting ongoing challenges within the company. In terms of performance metrics, the stock has shown a mixed trend over various time frames. Over the past week, it has gained 4.54%, contrasting sharply with the China Shanghai Composite, which fell by 5.81%. However, the one-month performance indicates a positive growth of 10.03%, while the year-to-date performance remains negative at -4.35%. Long-term growth appears to be a concern, with net sales increasing at an annual rate of only 7.88% over the last five years, and operating profit declining at -2.67%. The company's return on capital employed (ROCE) stands at a low 5.15%, and net profit has seen a significant drop of 30.36% in the latest quarter. Overall, Shaanxi Panlong Pharmaceutical Group's current market position reflects a challenging environment, particularly when compared to the broader market trends.